Crossmark

Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS

Crossref DOI link: https://doi.org/10.1186/s40478-019-0673-y

Published Online: 2019-02-12

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gittings, Lauren M.

Foti, Sandrine C.

Benson, Bridget C.

Gami-Patel, Priya

Isaacs, Adrian M.

Lashley, Tammaryn https://orcid.org/0000-0001-7389-0348
Funding

Funding for this research was provided by:

Alzheimer’s Research UK (ARUK-SRF2015-2)

H2020 European Research Council (648716 - C9ND)
License Information

Text and Data Mining valid from 2019-02-12
More Information

Article History

Received: 1 February 2019

Accepted: 3 February 2019

First Online: 12 February 2019

Ethics approval and consent to participate

: This study was approved by the National Hospital for Neurology and Neurosurgery and Institute of Neurology Joint Research Ethics Committee.

: All authors have approved the manuscript.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.